The differential diagnosis of patients with early non-ischaemic dilated cardiomyopathy (DCM) and those with physiological adaptation to exercise ('athlete's heart') may be difficult as many of the morphological adaptations are shared in the two conditions. Increased physical fitness is becoming more common in later adulthood, a group in whom there may be even more diagnostic difficulty. We hypothesized that tissue characterization using cardiovascular magnetic resonance (CMR) T 1 and T 2 mapping would be able to differentiate between patients with left ventricular (LV) dilatation due to early DCM and exercisers.
Introduction
Cardiovascular magnetic resonance (CMR) imaging is increasingly becoming an integral part of the assessment of myocardial function and structure due to its accuracy and reproducibility in the measurement of left ventricular (LV) dimensions and function and its unique ability to non-invasively characterize myocardial tissue. 1, 2 The assessment of LV ejection fraction (LVEF) is a particularly important indication for CMR, for example in non-ischaemic dilated cardiomyopathy (DCM). DCM is the final common pathway of a number of cardiomyopathies, but is typically characterized by a dilated left ventricle with an impairment of systolic function in the absence of significant obstructive coronary artery disease and in the presence of normal wall thickness. 3, 4 LV dilatation, despite being considered as the hallmark of DCM, is not always diagnostic of a pathological cardiomyopathy; it can develop as an adaptive response to chronically sustained physical exertion, known as 'athlete's heart'. Intensive aerobic (endurance) exercise typically causes LV dilatation with significantly increased biventricular diameters and volumes, and consequently a mildly reduced LVEF (typically 45 -55%). 5 -7 These changes have also been seen in older patients undergoing marathon training. 8 Using simple parameters, such as LVEF, could potentially lead to diagnostic problems in the differentiation of early DCM and physiological adaptation to exercise, especially in middle-aged and older patients, in whom the pretest probability of cardiomyopathy is probably higher. This is compounded by the fact that an increasing number of older adults are taking up more intense exercise. 9 Correct early diagnosis of cardiomyopathy is of vital importance for future prognosis and management. Late gadolinium enhancement (LGE) imaging during CMR can also add diagnostic confidence, allowing the identification of specific aetiologies of DCM. 10 The presence of LGE, which is typically midwall and occurs in 30% of patients with DCM, 11 is also an adverse prognostic indicator. 12, 13 Nevertheless, healthy older marathon runners have also been shown to have the present of LGE, which might again cause some diagnostic uncertainty.
9,14
Recently, T 1 -and T 2 -mapping techniques have been utilized to provide further myocardial tissue characterization information in addition to LGE. These techniques rely on the fundamental magnetic properties of the myocardium in order to identify (among others) diffuse fibrosis and oedema.
15,16 T 1 -and T 2 -mapping techniques have been shown to identify diffuse myocardial disease in patients with DCM, which may occur prior to the development of more focal changes. 15 -17 To the best of our knowledge, the utility of T 1 and T 2 mapping in the diagnosis of physiological adaptation to exercise has not yet been evaluated. In this study, we wished to evaluate the utility of T 1 and T 2 mapping in differentiation of athletes and patients with mild DCM, potentially allowing for improvement in diagnostic confidence where the assessment of LVEF and LGE may still leave doubt.
Methods

Patient selection
We evaluated three separate cohorts of middle-aged male patients who all underwent CMR examination. The first cohort, who acted as the control group, consisted of 21 healthy control patients without any history of cardiovascular disease, on no medications, and normal resting electrocardiograms. The second group consisted of 21 males, prospectively recruited, with a history of regular aerobic exercise ('exercisers') and mildly impaired or borderline LVEF using echocardiography (LVEF using Simpson's biplane 45 -50%). All patients in this group undertook over 6 h of intensive aerobic exercise per week at an amateur level (predominantly running). These patients also had no history of cardiac disease, hypertension, and were on no medications, with diagnosis of cardiomyopathy excluded using case note review and the absence of an ischaemic pattern of LGE or significant valvular disease on CMR examination. The final group consisted of 16 patients with confirmed DCM (LVEF 40 -50% by echocardiography) and without a history of engagement in significant aerobic exercise and no family history of cardiomyopathy. All of these patients had also undergone comprehensive evaluation to exclude ischaemic cardiomyopathy with invasive or CT coronary angiography or SPECT imaging (modality chosen at the discretion of their clinician). Additionally, other causes of cardiomyopathy, such as hypertension or significant valvular heart disease, were also excluded based on clinical evaluation. As a final discriminator, any patients with a subendocardial or transmural pattern of LGE, suggestive of ischaemic cardiomyopathy, were also excluded. All DCM patients were on at least an ACE inhibitor and beta-blocker as per the current guidelines for management of heart failure. The study was approved by our local ethics committee and all patients gave written informed consent to undergo CMR examination.
CMR protocol and analysis
All patients underwent a systematic CMR examination using a 1.5 T MRI scanner (Magnetom Avanto, Siemens, Erlangen, Germany). Following the acquisition of localizers, cine imaging was carried out using steady-state free precession imaging (SSFP) to acquire a stack of short-axis slices and three long-axis views to fully assess LV mass, dimensions, and function, as previously described. 18 Following this, we acquired native T 1 maps in three slices representing the basal, mid, and apical slices using a modified Look-Locker inversion recovery (MOLLI) sequence. 19 We then acquired T 2 maps in the same three short-axis slices immediately after using an SSFP-prepared sequence. 20 Three T 2 -weighted images were obtained during one breath-hold at 0, 24, and 55 ms, allowing generation of the T 2 time for each individual voxel. Again, a motioncorrection algorithm was applied to allow for movement artefact. Typical imaging parameters were TE 1.1 ms, repetition time 260 ms, flip angle 708, bandwidth 947 Hz/pixel, matrix 160 × 105 pixels, spatial resolution 2.6 × 2.1 × 8.0 mm, and slice thickness 8 mm.
After acquisition of these images, an intravenous injection of gadolinium contrast was given (0.15 mmol/kg of gadobutrol; Gadovist, Bayer, Berlin, Germany). Ten minutes after this injection, an MOLLI sequence was acquired to obtain three short-axis post-contrast T 1 maps. Immediately following acquisition of post-contrast T 1 maps, LGE images were acquired as previously described. 18 
Image analysis
All analysis was carried out using the proprietary software (Argus, Siemens, Erlangen, Germany). LV mass and function was assessed by manually tracing round the endocardial (excluding papillary muscles) and epicardial borders to obtain ejection fraction.
To assess myocardial T 1 and T 2 times, as wide a region of interest as possible was drawn within the septum of the basal and mid-ventricular slices, taking care to avoid blood pool signal. The average of the two values was taken in order to have as a representative value of the myocardium as possible. The apical slice and the lateral walls were excluded as we found that these areas were more likely to be affected by artefact. Once the region of interest was drawn, T 1 and T 2 times were automatically displayed on the workstation. On T 1 -weighted images, a large representative region of interest was also drawn within the blood pool. Motion correction was not used for analysis of the maps.
The presence of LGE was determined by the presence of areas of enhanced myocardium with signal intensity 5 standard deviations higher than non-enhanced myocardium.
Calculation of extracellular volume
A blood sample was taken immediately prior to CMR scanning to analyse the full blood count. The haematocrit was obtained, allowing for
calculation of extracellular volume (ECV) using the following equation: ECV ¼ (1 2 haematocrit) × (DR1 myocardium /DR1 blood ). 21 
Statistical analysis
All continuous variables are presented as mean + SD, whereas noncontinuous variables are expressed as percentages. Comparisons between multiple groups were carried out using a one-way ANOVA with Bonferroni correction applied for multiple group testing. Statistical significance was set at ,0.05. Correlations were assessed by Pearson's correlation co-efficient. Binary logistic regression was used to assess the value of T 1 and T 2 mapping parameters for identification of DCM patients. Native T 1 and T 2 values and calculated ECV were incorporated into univariable analysis as continuous variables, and significant predictors (P , 0.05) were then included into multivariable analysis. Sensitivity and specificity was analysed using receiver-operator characteristic (ROC) curves, in order to obtain the area under the curve (AUC). All statistical analysis was carried out using SPSS 22.0 (IBM, Armonk, NY, USA).
Results
In total, 58 males were evaluated-21 with a history of aerobic exercise, 16 with mild DCM, and 21 age-matched healthy controls. The average age of the cohort was 47.9 + 14.5 years.
Correlations between tissue characteristics and LV function
Myocardial T 2 times were significantly correlated with both native T 1 times (r ¼ 0.53, P , 0.001) and ECV (r ¼ 0.56, P , 0.001). There was a strong correlation between native T 1 and ECV (r ¼ 0.69, P , 0.001).
LVEF was also correlated with both native T 1 (r ¼ 20.40, P , 0.001) and ECV (r ¼ 20.43, P , 0.001). T 2 values were not significantly correlated with either LVEF. There were no significant correlations between age, native T 1 , ECV, or T 1 values.
Differentiation of aerobic exercisers, DCM patients, and controls
Both exercisers and DCM patients had significantly increased LV volumes and reduced LVEF compared with control ( Table 1) . Exercisers also had an increased LV mass, compared with both controls and DCM patients.
DCM patients were more likely to have LGE than both controls and exercisers (P ¼ 0.027). There was no subendocardial or transmural LGE in any group to suggest prior myocardial infarction or ischaemia-four patients in the DCM group had midwall the present of LGE, whereas two exercisers had small amounts of the present of LGE at the right ventricular insertion points.
Both native T 1 and ECV were significantly different between athletes and DCM patients (native T 1 : 957 + 32 vs. 1017 + 42 ms, P , 0.001; ECV: 26.3 + 3.6 vs. 31.2 + 4.1%, P , 0.001, respectively). Athletes had a similar native T 1 and ECV to controls (Figures 1 and  2) . T 2 relaxation time was also similar between controls and athletes (52.9 + 3.3 vs. 52.8 + 3.2 ms, respectively) and significantly lower than DCM patients (55.9 + 4.4 ms, P ¼ 0.024 between all three groups).
Native T 1 (OR 1.05; 95% CI 1.02 -1.08, P ¼ 0.002), ECV (OR 1.38; 95% CI 1.09 -1.75, P ¼ 0.009), and T 2 (OR 1.23; 95% CI 1.01 -1.49, P ¼ 0.042) were all significantly associated with the presence of DCM in univariable analysis. Using multivariable logistic regression analysis, native T 1 was the only independent discriminator between athletes and DCM patients (OR 1.06; 95% CI 1.01 -1.10, P ¼ 0.015; Table 2 ). Using ROC analysis, the AUC for differentiation between athletes and DCM patients was 0.91 (95% CI 0.82 -1.00, P , 0.001), which was significantly better than both ECV (AUC 0.82; 95% CI 0.67 -0.98, P ¼ 0.002) and T 2 relaxation time (AUC 0.74; 95% CI 0.56-0.92, P ¼ 0.02; Figure 3 ).
Discussion
In this study, we identified several important findings. First, in the largest cohort so far evaluated, we have shown the incremental diagnostic utility of both T 1 and T 2 mapping to identify changes in the myocardium in patients with DCM. Secondly, we have shown that native T 1 especially might be used to differentiate between middle-aged exercisers with mildly impaired LV function due to physiological adaptation and middle-aged patients with early DCM.
Both T 1 and T 2 mapping have emerged as valuable tools in the CMR assessment of non-ischaemic cardiomyopathies.
22,23 T 2 mapping identifies myocardial oedema secondary to acute myocardial injury. 17 Native T 1 times reflect both interstitial and myocyte signals, complementing T 2 imaging with a high correlation between native T 1 and T 2 times. Finally, the assessment of T 1 values after the administration of intravenous gadolinium (which shortens tissue T 1 time) allows the measurement of the ECV, which can be a measure of diffuse fibrosis. We have shown, similar to other studies, that these parameters are associated with the presence of DCM and are correlated with adverse remodelling in this condition. 15, 16 Additionally, we have also shown, for the first time, that these parameters can provide diagnostic confidence at the 1.5 T field strength, which is more commonly used in routine clinical practice. 24 Puntmann et al. 15 studied 27 patients with DCM (included in a cohort with 25 HCM patients) and found that native T 1 times were longer in DCM patients compared with controls, while postcontrast T 1 values were lower and ECV was higher. The authors found that native T 1 was the best predictor of cardiomyopathy. In another study by Dass et al., 16 the authors evaluated 18 DCM patients (along with 28 HCM patients) and again found that native T 1 values were increased in DCM patients compared with controls and were significantly correlated with global circumferential strain. Similar to the above studies, we also found that native T 1 was significantly higher in patients with mild DCM. ECV measurement using T 1 mapping has also been shown to correlate extremely well with myocardial fibrosis measured histopathologically in patients with DCM. 25 In this study by aus dem Siepem et al., the authors also showed that non-invasive ECV was even able to differentiate between patients with mild DCM and controls, similar to our study. This again would suggest that the presence of an increased ECV could be useful in risk stratification and management of these patients. Numerous myocardial adaptations occur in endurance-trained athletes. 5, 7, 8, 14 These include an increase in end-diastolic diameter, volume, and mass, leading to a reduction in LVEF. 6 These findings were also reflected in our study. LV mass tends to increase in T 1 mapping for diagnosis of DCM in middle-aged patients both endurance-and strength-trained athletes, but also increases in DCM due to the increase in LV size, potentially causing diagnostic difficulty. 26 This has important clinical implications, particularly in the differentiation between the normal cardiac adaptations to exercise and athletes, in whom the changes in myocardial structure and function are actually the early signs of DCM. Current non-invasive techniques have limited ability to differentiate between the two, and detraining is often unattractive and impractical for athletes.
The implications of an incorrect diagnosis-either as athlete's heart or early DCM, may lead to unnecessary exclusion from sport, or sudden cardiac death (SCD) if undertaking exercise. Additionally, the erroneous labelling of early DCM would lead to long-term treatment incorrectly directed at heart failure. Our finding that native T 1 mapping seems to be able to differentiate between athletes and patients with early DCM might provide an extra parameter to support the diagnosis in these cases. The importance of these findings is perhaps their potential use in identification of athletes at risk of sudden death, in whom the first presentation of any cardiac abnormality is that of SCD. Vigorous exertion can act as a substrate for ventricular arrhythmias in people with an underlying abnormal myocardium. 27 One theory for this is that repeated myocardial injury (causing an increase in troponin release) leads to fibrosis and scarring, which may be identified using LGE. 28, 29 These areas of fibrosis lead to an increased susceptibility to ventricular arrhythmias. ECV evaluation using T 1 mapping may also identify these areas; however, whether the above is valid also in athletic hearts remains to be established pathologically. Nevertheless, the overwhelming majority of athletes do not have fibrosis that can be seen using LGE or ECV imaging. Native T 1 mapping appears to identify other processes that are not purely related to fibrosis, for example myocardial inflammation represented by oedema (also seen using T 2 mapping, for which there is a strong correlation in our study). 30 Speculatively, native T 1 mapping may also identify early changes in myocardial function and metabolism, although large studies are awaited to understand the mechanisms and their clinical impact. 16 The finding of increased T 2 values in patients with cardiomyopathy has been recognized in other studies and is possibly due to myocardial oedema caused by injury and inflammation related to ROC curve for diagnosis of DCM using native T 1 , ECV, and T 2 mapping T 1 mapping for diagnosis of DCM in middle-aged patients the cardiomyopathic process. 17, 31, 32 Oedema is typically present within 4 -6 weeks of a myocardial insult, and is thus reflective of an active or recent process. The reason for its presence in the myocardium of patients with idiopathic DCM is unclear; however, its absence in athletes in our study might perhaps suggest that the physiological adaptation seen in athletes is not related to any persistent and ongoing myocardial damage. T 2 values do, however, correlate with T 1 and so, the increase in T 2 values may also reflect other underlying processes. We speculate that the similarity in values seen between controls and exercisers is because these pathological processes contributing to the development of irreversible myocardial injury in DCM do not occur in athletes despite the ventricular remodelling caused by exercise. Fibrosis is not a common feature in athletes, and this may be reflected in our finding of 'normal' T 1 , T 2 , and ECV values in our cohort of exercisers. In a study of older athletes, Mohlenkamp et al. 9 reported that only 12% of the athletes had the present of LGE. Nevertheless, LGE does represent a different pattern of fibrosis to T 1 and T 2 mapping, neither of which have been evaluated in a large cohort of athletes (as yet).
Both native T 1 values and ECV are known to increase with age, whereas post-contrast T 1 values decrease with age. 33 In our study, there were no significant correlations between age and T 1 or T 2 mapping parameters, although we believe that this is simply due to the small cohort. Despite the fact that there is an age-related increase in T 1 values, we have shown that this parameter could potentially still be used as a diagnostic tool. This is particularly important given that older healthy exercisers may still have the present of LGE, meaning that the presence (or absence) of LGE alone might not confirm or refute the diagnosis of DCM. 9, 34 It is important to note that there was a significant overlap in the T 1 and in particular T 2 values in all three groups. This is common to the mapping techniques, changes in which reflect a continuous spectrum ranging from normality to pathological, in contrast to LGE which is either present or absent.
Limitations
Our study does have some limitations. First, it is a single-centre study with a relatively small cohort, although to the best of our knowledge, this is the largest cohort studied in this area. Nevertheless, larger studies are required to confirm our findings and identify any potential prognostic benefit. Additionally, due to the small numbers, there is some degree of overlap present between the three groups, which could potentially be resolved with a larger study. A further difficulty is the lack of standardization (as yet) between vendors regarding mapping techniques. Hence, although our results suggest a high level of repeatability, larger multicentre, multivendor studies are still needed to refine the results.
Secondly, the lack of histological correlation in this study is a limitation as this could have provided further information. This does, however, reflect the decreasing use of endomyocardial biopsy in routine clinical practice. Also, biopsy itself is limited by sampling error. Associated with the lack of histological diagnostic confirmation, the patients in this study undoubtedly represent a small fraction of wide spectrum of DCM, such as those with genetic causes. Indeed, it was not possible to rule out post-inflammatory states for example. Thirdly, although measurement of T 1 and T 2 times in the septum is accepted in the current literature as being an adequate surrogate for the whole myocardium, both sequences still need to be optimized to allow accurate quantification in the lateral wall and apex without artefact. We also only examined males as T 1 parameters show gender-specific variation. 33, 35 This study would need to be repeated in order to validate the findings in females. We only carried out post-contrast T 1 imaging at one time point, 10 min after gadolinium administration. The optimal time for post-contrast T 1 mapping has yet to be validated, although 10 min has been used in previous studies for determination of ECV. 15, 36 To maintain consistency, we adhered to imaging at 10 min for all patients in our protocol.
Conclusions
Both T 1 -and T 2 -mapping parameters could potentially be used to predict the presence of mild DCM. T 1 mapping in particular could potentially have the ability to differentiate between patients with early non-ischaemic DCM and middle-aged exercisers.
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